Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Latrepirdine

No Benefit for Dimebon in Huntington’s

An antihistamine that failed to work in Alzheimer’s disease also fell short of expectations in Huntington’s disease, researchers reported.

In a randomized controlled trial, latrepirdine (Dimebon) didn’t improve cognition or global function compared with placebo, Ray Dorsey, MD, of Johns Hopkins, and colleagues reported online in the Archives of Neurology.

Currently, medications can mitigate… No Benefit for Dimebon in Huntington’s   



Parkinson’s Disease Dementia

alzheimer sufferer1 - beta secretase1 - cognitive changes1 - brain health1 - risk of parkinson's1 - degeneration theory1 - changes in mood1 - loss of memory3 - non-familial parkinson's1 - lucretius1 - mental impairment1 - alzheimer's warning signs1 - apoe genotype1 - alzheimer's symptoms2 - dementia workers1 - alzheimer's and parkinson's diseases1 - fish consumption1 - burden of dementia1 - korsakoff's syndrome10 - experimental alzheimer's drug1 - cjd2 - loss of neuronal connections1 - quit smoking1 - department of psychiatry and psychotherapy1 - dementia of lewy body1 - predict dementia2 - dementiaantipsychotic drugs1 - symptoms of alzheimer's2 - ad risk factors1 - caregiving2 -